Below are the most recent publications written about "Receptor, trkA" by people in Profiles.
-
Tymanskyj SR, Escorce A, Karthikeyan S, Ma L. Optogenetic control of receptor-mediated growth cone dynamics in neurons. Mol Biol Cell. 2025 Feb 01; 36(2):br5.
-
Lin R, Mallick AB, Wang ZX, Brown SA, Lu B, Jiang W. Identification of dual STRN-NTRK2 rearrangements in a high grade sarcoma, with good clinical response to first-line larotrectinib therapy. Diagn Pathol. 2023 Oct 21; 18(1):116.
-
Yang JCH, Brose MS, Castro G, Kim ES, Lassen UN, Leyvraz S, Pappo A, L?pez-R?os F, Reeves JA, Fellous M, Penault-Llorca F, Rudzinski ER, Tabatabai G, Vassal G, Drilon A, Trent J. Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib. BMC Cancer. 2022 Jun 07; 22(1):625.
-
Kummar S, Italiano A, Brose MS, Carlson JJ, Sullivan SD, Lassen U, Federman N. Diagnosis and management of TRK fusion cancer. Am J Manag Care. 2022 01; 28(2 Suppl):S15-S25.
-
Lasota J, Chlopek M, Lamoureux J, Christiansen J, Kowalik A, Wasag B, Felisiak-Golabek A, Agaimy A, Biernat W, Canzonieri V, Centonze G, Chmielik E, Daum O, Dubov? M, Dziuba I, Goertz S, G?zdz S, Guttmejer-Nasierowska A, Haglund C, Halon A, Hartmann A, Inaguma S, Izycka-Swieszewska E, Kaczorowski M, Kita P, Kolos M, Kopczynski J, Michal M, Milione M, Okon K, Peksa R, Pyzlak M, Ristim?ki A, Rys J, Szostak B, Szpor J, Szumilo J, Teresinski L, Waloszczyk P, Wejman J, Wesolowski W, Miettinen M. Colonic Adenocarcinomas Harboring NTRK Fusion Genes: A Clinicopathologic and Molecular Genetic Study of 16 Cases and Review of the Literature. Am J Surg Pathol. 2020 02; 44(2):162-173.
-
Kyker-Snowman K, Hughes RM, Yankaskas CL, Cravero K, Karthikeyan S, Button B, Waters I, Rosen DM, Dennison L, Hunter N, Donaldson J, Christenson ES, Konstantopoulos K, Hurley PJ, Croessmann S, Park BH. TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic properties. Breast Cancer Res Treat. 2020 Feb; 179(3):631-642.
-
Milman T, Hu DN, McCormick SA, Eagle RC, Crawford JB, Chin K, Shields CL, Shields JA, Char DH, Finger PT. Expression of neurotrophin receptors by retinoinvasive uveal melanoma. Melanoma Res. 2012 Apr; 22(2):164-8.
-
Rampersaud AA, Oblinger JL, Ponnappan RK, Burry RW, Yates AJ. Gangliosides and growth factor receptor regulation. Biochem Soc Trans. 1999 Aug; 27(4):415-22.
-
Miknyoczki SJ, Chang H, Klein-Szanto A, Dionne CA, Ruggeri BA. The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma. Clin Cancer Res. 1999 Aug; 5(8):2205-12.
-
Miknyoczki SJ, Lang D, Huang L, Klein-Szanto AJ, Dionne CA, Ruggeri BA. Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: expression patterns and effects on in vitro invasive behavior. Int J Cancer. 1999 May 05; 81(3):417-27.